Clinical Differences between ADHD Symptoms Frequency Subgroups.

A: ADHD symptoms severity subgroup differences in percent of change in ADHD medications since MC treatment initiation; B: ADHD symptoms severity subgroup differences in percent of stopping all ADHD medications since MC treatment initiation; C: ADHD symptoms severity subgroup differences in anxiety scores; D: ADHD symptoms severity subgroup differences in CBN monthly dose consumption (mg); E: ADHD symptoms severity subgroup differences in THC monthly dose consumption (mg).

ADHD, attention deficit hyperactivity disorder; ASRS, adult ADHD self-report scale; CBN, cannabinol; High, high subgroup (patients that reported total ASRS scores ≥3.18); Low, low subgroup (patients that reported total ASRS scores ≤3.17); NS, non-significant; THC, Δ-9-tetrahydrocannabinol.